Home LiteratureArticle Details
PMID: 2852521 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

The negative inotropic effect of nicorandil is independent of cyclic GMP changes: a comparison with pinacidil and cromakalim in canine atrial muscle.

British journal of pharmacology ·Vol. 95 ·No. 2 ·1988-10-00 ·Pages 393-8

Yanagisawa T, Hashimoto H, Taira N

Abstract

1. The negative inotropic effects of nicorandil, a nitrate with K-channel opening properties, have been compared with those of pinacidil, cromakalim and nifedipine, in canine right atrial muscle. 2. Cromakalim, pinacidil and nicorandil all produced a negative inotropic effect. However, even at their maximally effective concentrations, the force of contraction remained at about 10% of control levels, whereas contraction was abolished by nifedipine. 3. The pD2 values for the negative inotropic effects of cromakalim, pinacidil and nicorandil were 5.93, 5.37, and 4.35, respectively. 4. The negative inotropic effects of cromakalim (3 x 10(-5)M), pinacidil (3 x 10(-5) M and 3 x 10(-4) M) and nicorandil (3 x 10(-5) M) were not accompanied by changes in cyclic AMP and cyclic GMP levels, whereas that of 3 x 10(-4) M nicorandil was accompanied by an increase in cyclic GMP but not cyclic AMP concentrations. 5. The negative inotropic effect produced by 3 x 10(-4) M nicorandil was greatly reduced by 10(-2) M tetraethylammonium, whereas the increase in cyclic GMP produced by this concentration of nicorandil was not significantly changed. Sodium nitroprusside (10(-3) M) produced a large increase in cyclic GMP concentrations but had no significant negative inotropic effect. 6. It is concluded that the negative inotropic effects of nicorandil like those of cromakalim and pinacidil do not result from an increase in cyclic GMP concentrations. Instead these effects may be due to their action as K-channel openers.

MeSH Terms
Animals Anti-Arrhythmia Agents Antihypertensive Agents/pharmacology Benzopyrans/pharmacology Cromakalim Cyclic AMP/metabolism Cyclic GMP/metabolism Dogs Female Guanidines/pharmacology In Vitro Techniques Male Monoamine Oxidase Inhibitors/pharmacology Myocardial Contraction/drug effects Myocardium/metabolism Niacinamide/analogs & derivatives,pharmacology Nicorandil Nifedipine/pharmacology Pinacidil Potassium Channels/drug effects,metabolism Pyrroles/pharmacology Tetraethylammonium Compounds/pharmacology Vasodilator Agents/pharmacology
Chemicals
Anti-Arrhythmia Agents Antihypertensive Agents Benzopyrans Guanidines Monoamine Oxidase Inhibitors Potassium Channels Pyrroles Tetraethylammonium Compounds Vasodilator Agents Cromakalim Niacinamide Nicorandil Pinacidil Cyclic AMP Cyclic GMP Nifedipine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Yanagisawa T
Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan.
Hashimoto H
Taira N
References (26)
26 references, click to expand
  1. The effect of the duration of the action potential on contraction in the mammalian heart muscle.
    Pflugers Arch Gesamte Physiol Menschen Tiere. 1968;299(1):66-82 PMID: 5243673
  2. Pinacidil increases the background potassium current in single ventricular cells.
    Eur J Pharmacol. 1987 Sep 2;141(1):139-41 PMID: 2444443
  3. Cyclic GMP as possible mediator of coronary arterial relaxation by nicorandil (SG-75).
    J Cardiovasc Pharmacol. 1983 May-Jun;5(3):364-70 PMID: 6191133
  4. Relationship between relaxation and cyclic GMP formation caused by nicorandil in canine mesenteric artery.
    Naunyn Schmiedebergs Arch Pharmacol. 1983 May;322(4):319-21 PMID: 6306488
  5. Effects of nicorandil and its interaction with isoproterenol on force of contraction and cyclic nucleotide levels of canine atrial muscle: comparison with carbachol.
    J Cardiovasc Pharmacol. 1983 Sep-Oct;5(5):878-82 PMID: 6195480
  6. Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists.
    J Pharmacol Exp Ther. 1971 Apr;177(1):1-12 PMID: 5566763
  7. [BAY a 1040--a highly potent Ca ++ -antagonistic inhibitor of electro-mechanical coupling processes in mammalian myocardium].
    Arzneimittelforschung. 1972 Jan;22(1):22-33 PMID: 4259147
  8. Effect of 2-nicotinamidethyl nitrate (SG 75) on coronary circulation.
    Jpn Heart J. 1978 Jan;19(1):112-24 PMID: 148520
  9. Pharmacological profile of a new coronary vasodilator drug, 2-nicotinamidoethyl nitrate (SG-75).
    Clin Exp Pharmacol Physiol. 1979 May-Jun;6(3):301-16 PMID: 157241
  10. Circumstantial evidence for increased potassium conductance of membrane of cardiac muscle by 2-nicotinamidoethyl nitrate (SG-75).
    Jpn J Pharmacol. 1979 Oct;29(5):687-94 PMID: 161336
  11. N''-cyano-N-4-pyridyl-N'-1,2,2-trimethylpropylguanidine, monohydrate (P 1134): a new, potent vasodilator.
    Experientia. 1980 Apr 15;36(4):445-7 PMID: 7379920
  12. Effect of 2-nicotinamidethyl nitrate (SG-75) on the membrane potential of left atrial muscle fibres of the dog. Increase in potassium conductance.
    Naunyn Schmiedebergs Arch Pharmacol. 1980 May;312(1):69-76 PMID: 6446686
  13. Differential responses to carbachol, sodium nitroprusside and 8-bromo-guanosine 3',5'-monophosphate of canine atrial and ventricular muscle.
    Br J Pharmacol. 1981 Jun;73(2):393-9 PMID: 6263387
  14. Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle.
    J Pharmacol Exp Ther. 1982 Jun;221(3):775-83 PMID: 6283063
  15. Involvement of cyclic AMP in the positive inotropic effect of OPC-8212, a new cardiotonic agent, on the canine ventricular muscle.
    Jpn J Pharmacol. 1984 Nov;36(3):379-88 PMID: 6097725
  16. The relaxant action of nicorandil in guinea-pig isolated trachealis.
    Br J Pharmacol. 1986 Jan;87(1):117-27 PMID: 2420397
  17. Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein.
    Br J Pharmacol. 1986 May;88(1):103-11 PMID: 3708211
  18. The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels.
    Br J Pharmacol. 1986 May;88(1):121-8 PMID: 2423172
  19. BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models.
    J Cardiovasc Pharmacol. 1986 Jul-Aug;8(4):798-804 PMID: 2427821
  20. Electrical and mechanical effects of BRL34915 in guinea-pig isolated trachealis.
    Br J Pharmacol. 1986 Oct;89(2):395-405 PMID: 2430658
  21. Lack of second messenger function of cyclic GMP in acetylcholine-induced negative inotropism.
    J Cardiovasc Pharmacol. 1986 Nov-Dec;8(6):1154-7 PMID: 2434740
  22. Effects of pinacidil on serotonin-induced contractions and cyclic nucleotide levels in isolated rat aortae: comparison with nitroglycerin, minoxidil, and hydralazine.
    J Cardiovasc Pharmacol. 1986 Nov-Dec;8(6):1195-200 PMID: 2434746
  23. Modification by nicorandil and carbachol of the inward calcium current in single cells of the guinea-pig heart.
    Tohoku J Exp Med. 1986 Dec;150(4):475-9 PMID: 2436351
  24. Evidence that the mechanism of the inhibitory action of pinacidil in rat and guinea-pig smooth muscle differs from that of glyceryl trinitrate.
    Br J Pharmacol. 1987 Jun;91(2):421-9 PMID: 3111575
  25. Evidence for inhibition by ICS 205-930 and stimulation by BRL 34915 of K+ conductance in cardiac muscle.
    Naunyn Schmiedebergs Arch Pharmacol. 1987 Jun;335(6):692-6 PMID: 2442630
  26. Effects of some inhibitors of ionic permeabilities on ventricular action potential and contraction of rat and guinea-pig hearts.
    J Electrocardiol. 1968;1(1):19-29 PMID: 5699491
Article Info
Journal
British journal of pharmacology
Abbr.
Br J Pharmacol
ISSN
0007-1188
Published
1988-10-00
Pages
393-8
Language
English
Region
England
NLM ID
7502536
PMCID
PMC1854162
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com